Keywords: Xarelto, Oulmonary embolism, Bayer, Janssen, Johnson & Johnson,

Strong results for Bayer's Xarelto in treating pulmonary blood clots

Article | 27 March 2012

Print This

German drugs and crops sciences group Bayer (BAY: DE), and partner Janssen, part of US health care major Johnson & ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in